Sarepta Therapeutics, Inc. SRPT Elevidys — Intangible Assets Net Excluding Goodwill
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s elevidys — intangible assets net excluding goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s elevidys — intangible assets net excluding goodwill?
- Sarepta Therapeutics, Inc. (SRPT) reported elevidys — intangible assets net excluding goodwill of $19M in Q4 2025.
- What does elevidys — intangible assets net excluding goodwill mean?
- Measures the net book value of identifiable non-physical assets, such as patents, licenses, or intellectual property, specifically attributed to the product segment. This reflects the company's investment in the long-term competitive advantage and proprietary technology underlying the product. It is a key indicator of the asset base supporting future revenue streams.